Ets a: Portada > Recerca > Ajuts a la recerca

Ajuts a la recerca

IMI -Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)


EU- Innovative Medicines Initiative


Specific challenge

Type 1 diabetes mellitus (T1DM) is a chronic disease affecting worldwide around 17 million people. The disease T1DM may present at any age, but most typically presents in early life with a peak around puberty. The incidence rate is highest in Europe, affecting altogether 22 /100.000 per year, with major regional differences and an overall 25% higher incidence rate than in the US (www.diapedia.org). The rising incidence of T1DM appears to be explained by faster conversion from islet-antigen seropositivity to manifest β-cell failure. However, the scientific insights to the triggering events, disease susceptibilities, and subsequent pathophysiological events leading to failing β-cell function and beta cell loss in human disease are quite limited. Rational disease modifying therapeutic approaches to address T1DM are lacking.

Termini oficial

Stage 1 Submission deadline: 12 November 2014 – 17:00:00 Brussels time

Termini IISPV

Declaration of interest: IISPV's deadline: August 31, 2014 (europa@iispv.cat) Full proposal: IISPV's deadline: October 29, 2014

Enllaços relacionats


Fes-ho córrer

  • Facebook
  • TwitThis
  • LinkedIn
  • eMail


IISPVInstitut d'Investigació Sanitària Pere Virgili (IISPV)

Work Centre d'R+D+I en Nutrició i Salut
Avda. de la Universitat, 1 - 2a planta
E-43204 Reus (Tarragona)

Tel. Work977 75 93 94 http://www.iispv.cathttp://www.iispv.cat

Generalitat de Catalunya

Universitat Rovira i Virgili (URV)

ICS - Institut Català de la Salut

Hospital Universitari Sant Joan de Reus

Centre de Recerca de Catalunya

Universitat Excel·lència - Universitat Rovira i Virgili - Investigació excel·lència - Postgrau Excel·lència

HR Excellence in Research

Institut Pere Mata, Hospital Psiquiàtric Universitari




© IISPV, tots els drets reservats